Literature DB >> 12449167

Health status measured with the CRQ does not predict mortality in COPD.

T Oga1, K Nishimura, M Tsukino, S Sato, T Hajiro, A Ikeda, M Mishima.   

Abstract

One purpose of measuring health status is to predict future outcomes. The aim of this study was to investigate the ability of health status derived from the Chronic Respiratory Disease Questionnaire (CRQ) to predict mortality in chronic obstructive pulmonary disease (COPD). One-hundred and forty-three patients with COPD were recruited. Health status, using the CRQ, and pulmonary function were measured at entry. Mortality after 7 yrs was then assessed. Univariate and multivariate Cox proportional hazards analyses were performed to predict those factors related to mortality. Of all the patients, 13 could not be followed up and 40 had died. The survival rate was 69% at 7 yrs. Univariate regression analyses revealed that the dyspnoea and emotional function domains and the total score of the CRQ were weakly but significantly correlated with mortality from all causes. However, multivariate regression analyses revealed that age and forced expiratory volume in one second were the strongest predictors of mortality, and health status was not a significant factor. Although there was a weak but significant relationship between health status and subsequent mortality in chronic obstructive pulmonary disease, it was not significant after an adjustment for age and pulmonary function. Mortality cannot be predicted from Chronic Respiratory Disease Questionnaire scores.

Entities:  

Mesh:

Year:  2002        PMID: 12449167     DOI: 10.1183/09031936.02.00303702

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  Outcomes in Cardiopulmonary Physical Therapy: Chronic Respiratory Disease Questionnaire (CRQ).

Authors:  Alyssa Chauvin; Laurel Rupley; Katie Meyers; Kristin Johnson; Jane Eason
Journal:  Cardiopulm Phys Ther J       Date:  2008-06

2.  Predictors of mortality in patients with stable COPD.

Authors:  Cristóbal Esteban; José M Quintana; Myriam Aburto; Javier Moraza; Mikel Egurrola; Pedro Pablo España; Julio Pérez-Izquierdo; Alberto Capelastegui
Journal:  J Gen Intern Med       Date:  2008-09-16       Impact factor: 5.128

3.  Self-management and quality of life in chronic obstructive pulmonary disease (COPD): The mediating effects of positive affect.

Authors:  Roberto P Benzo; Beatriz Abascal-Bolado; Megan M Dulohery
Journal:  Patient Educ Couns       Date:  2015-11-10

4.  The inspiratory capacity/total lung capacity ratio as a predictor of survival in an emphysematous phenotype of chronic obstructive pulmonary disease.

Authors:  Aimee French; David Balfe; James M Mirocha; Jeremy A Falk; Zab Mosenifar
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-13

5.  An evaluation of factors associated with completion and benefit from pulmonary rehabilitation in COPD.

Authors:  Afroditi K Boutou; Rebecca J Tanner; Victoria M Lord; Lauren Hogg; Jane Nolan; Helen Jefford; Evelyn J Corner; Christine Falzon; Cassandra Lee; Rachel Garrod; Michael I Polkey; Nicholas S Hopkinson
Journal:  BMJ Open Respir Res       Date:  2014-11-03

6.  The association between health-related quality of life and disease progression in idiopathic pulmonary fibrosis: a prospective cohort study.

Authors:  Sokai Akihiko; Handa Tomohiro; Oga Toru; Tanizawa Kiminobu; Ikezoe Kohei; Nakatsuka Yoshinari; Kubo Takeshi; Kanatani Kumiko; Chin Kazuo; Mishima Michiaki
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-03-09       Impact factor: 0.670

7.  Patient-reported dyspnea and health predict waitlist mortality in patients waiting for lung transplantation in Japan.

Authors:  Masaki Ikeda; Toru Oga; Toyofumi F Chen-Yoshikawa; Junko Tokuno; Takahiro Oto; Tomoyo Okawa; Yoshinori Okada; Miki Akiba; Satona Tanaka; Yoshito Yamada; Yojiro Yutaka; Akihiro Ohsumi; Daisuke Nakajima; Masatsugu Hamaji; Maki Isomi; Kazuo Chin; Hiroshi Date
Journal:  Respir Res       Date:  2021-04-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.